Matches in Nanopublications for { ?s ?p "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP225247.RAhhPJQRixWKi8kFnmWMYqJ-p9iN3wZbUYIcAvyUstSOU130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225247.RAhhPJQRixWKi8kFnmWMYqJ-p9iN3wZbUYIcAvyUstSOU130_provenance.
- NP309660.RAz3QlKovQNKVh8WgVdk9Q3kJKAzIjHTye8qnVukD3e_4130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309660.RAz3QlKovQNKVh8WgVdk9Q3kJKAzIjHTye8qnVukD3e_4130_provenance.
- NP938422.RAJaDuoR9TviroQZvhV8LZ8RMEzQwB5eO4A2l4uE4-YXM130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938422.RAJaDuoR9TviroQZvhV8LZ8RMEzQwB5eO4A2l4uE4-YXM130_provenance.
- NP573561.RAZ6YJIpYJpbsFHfRVjVF-31ME-K1jcNLbcqq0Yp193Ts130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573561.RAZ6YJIpYJpbsFHfRVjVF-31ME-K1jcNLbcqq0Yp193Ts130_provenance.
- NP657864.RA99mETs46KWHph2zoIY8VgMWxmcl-Jpi_bvuEKqO45i4130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657864.RA99mETs46KWHph2zoIY8VgMWxmcl-Jpi_bvuEKqO45i4130_provenance.
- NP904501.RAwyFQxdjt-0lNWCUWbWkR_GN7p_n9ZLmdi0U87dNxPVw130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904501.RAwyFQxdjt-0lNWCUWbWkR_GN7p_n9ZLmdi0U87dNxPVw130_provenance.
- NP904503.RAcgnaCZW2y4OQq92KmgypsYThExj-mubDHInUwmMFC_8130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904503.RAcgnaCZW2y4OQq92KmgypsYThExj-mubDHInUwmMFC_8130_provenance.
- NP657819.RAI9hvJvykPreZ11qFmN8uqssCZuhJJdrE8bkoPYeMNQo130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657819.RAI9hvJvykPreZ11qFmN8uqssCZuhJJdrE8bkoPYeMNQo130_provenance.
- NP573532.RAn02C68NUmV15WC5eB-VXdzslFfillVyzsNm6py8fV2U130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573532.RAn02C68NUmV15WC5eB-VXdzslFfillVyzsNm6py8fV2U130_provenance.
- NP904500.RAkp3NDEfXmaNTpZPQFSrH_cuZNjiIUUr7sw4SY9dJ2XU130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904500.RAkp3NDEfXmaNTpZPQFSrH_cuZNjiIUUr7sw4SY9dJ2XU130_provenance.
- NP904506.RAjebT57Sp_sZ8NUUEz1XdcIBnFlo-4EFtlK1vVQDjeys130_assertion description "[This study presents evidence that TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells promotes bone destruction by metastatic breast carcinoma cells, controlling expression of prometastatic factors including matrix metalloproteinase (MMP) 9 and COX2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904506.RAjebT57Sp_sZ8NUUEz1XdcIBnFlo-4EFtlK1vVQDjeys130_provenance.